Retex
Watertown · Founded 2022
About Retex
Retex is a pharmaceutical business that develops treatments and medicines for rare and chronic diseases by targeting ion channels and GPCRs.
Company Facts
- Founded: 2022
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Jan 2024)
- Website: retexpharma.com
- Phone: [email protected]
Canonical: https://fsome.com/organization/retex-8287257 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.